Healthcare / PR / Disease Awareness / Media Relations / GCC

    Bayer · Novartis · AbbVie: Healthcare PR & Disease Awareness

    Big pharma. Strict rules. Stronger coverage.

    Bayer · Novartis · AbbVie: Healthcare PR & Disease Awareness

    The Challenge

    Promoting pharmaceutical products in the GCC comes with strict regulatory boundaries. For three of the world's leading pharma brands, the challenge wasn't the science; it was finding a way to build meaningful public and professional awareness without crossing the line into direct product promotion.

    Our Approach

    We developed strategic communications campaigns that worked within the regulatory framework, shifting the focus from products to people. Disease awareness and treatment education became the narrative, delivered through the channels that carry the most credibility in healthcare: medical conferences, hospital partnerships, and expert voices. We facilitated interviews with local and international doctors, supported event visibility through press releases and media invitations, and ensured brand teams were prepared for any situation through media training and crisis communications readiness.

    Results

    The campaigns generated strong coverage across print, online, and broadcast media throughout the GCC, building brand credibility and public awareness in one of the most regulated communications environments in the world.

    Bayer · Novartis · AbbVie, project image 1Bayer · Novartis · AbbVie, project image 2Bayer · Novartis · AbbVie, project image 3

    Have a similar challenge?

    Talk to us

    Related case studies